Sequence LifeSciences
-
Langhorne’s Nexgel Transforms Near Disaster into ‘Three-Team Trade’ Acquisition
Despite the withdrawal of an investor, Langhorne-based Nexgel successfully finalized its acquisition of Celularity’s regenerative biomaterial products, a deal that is expected to nearly triple…
Founding Partners
Advertisement
Affiliate Partners
